VitaDX, a deep tech based in Rennes and Paris, develops and markets cancer diagnostic solutions combining artificial intelligence and image processing applied to cytology.
Its first solution, VisioCyt® Bladder, allows an early detection of bladder cancer, using a simple urine sample.
VitaDX was created in April 2015 to enhance a french patented technology, combining imagery and artificial intelligence. This technology, based on research carried out by researchers from the Institute of Molecular Sciences in Orsay (ISMO, UMR CNRS and Université Paris-Sud) and practitioners at CHU Bicêtre (AP-HP).
The company's mission is to develop innovative cancer diagnostic solutions that are more efficient, more reliable and have a significant impact on medical and economic systems to benefit the greatest number of patients.
After several years of development and a multi-center prospective clinical study, its first solution VisioCyt® Bladder - an in vitro diagnostic medical device dedicated to the diagnosis of bladder cancer - has obtained CE IVDR marking and has been available for prescription since late 2022/early 2023, thanks to a collaboration with partner anatomopathology laboratories (Médipath & XPath).
Allan holds a MBA in International Corporate Management from the University of Laval (Canada) and graduated from ESIEE, an engineering school, with a specialization in biotechnologies. He has skills in entrepreneurship and was an advisor for innovative startups in the medical field. He co-founded VitaDX and has led the project since 2013. As the acting CEO, he guides and implements strategic decisions of the company.
Allan holds a MBA in International Corporate Management from the University of Laval (Canada) and graduated from ESIEE, an engineering school, with a specialization in biotechnologies. He has skills in entrepreneurship and was an advisor for innovative startups in the medical field. He co-founded VitaDX and has led the project since 2013. As the acting CEO, he guides and implements strategic decisions of the company.
Thibaut is an engineer from the Institut d'Optique specialized in Signal and Image Processing. At the CNRS, he initiated with the researchers at the origin of the patent exploited by VitaDX, the first technical developments. Passionate about data analysis and artificial intelligence, he is in charge of all the image processing and machine learning algorithm’s development. As CTO, his mission is to enable the transition from a laboratory method to an industrial solution, which can be commercialized.
Thibaut is an engineer from the Institut d'Optique specialized in Signal and Image Processing. At the CNRS, he initiated with the researchers at the origin of the patent exploited by VitaDX, the first technical developments. Passionate about data analysis and artificial intelligence, he is in charge of all the image processing and machine learning algorithm’s development. As CTO, his mission is to enable the transition from a laboratory method to an industrial solution, which can be commercialized.
Marie is a biotechnology engineer who graduated from UTC Compiègne. With more than 25 years of experience in marketing and sales in healthcare, notably in oncology, she joined VitaDX in May 2022 to support it in its commercial deployment.
Marie is a biotechnology engineer who graduated from UTC Compiègne. With more than 25 years of experience in marketing and sales in healthcare, notably in oncology, she joined VitaDX in May 2022 to support it in its commercial deployment.
Raphaël has extensive experience in quality and regulatory management within companies specializing in medical devices through the structuring of a quality management system and CE marking applications for the marketing of medical solutions. Raphaël is in charge of structuring the quality and regulatory processes within VitaDX and he also supervises the entire regulatory strategy to ensure complete consistency with the company's strategy.
Raphaël has extensive experience in quality and regulatory management within companies specializing in medical devices through the structuring of a quality management system and CE marking applications for the marketing of medical solutions. Raphaël is in charge of structuring the quality and regulatory processes within VitaDX and he also supervises the entire regulatory strategy to ensure complete consistency with the company's strategy.
Allan holds a MBA in International Corporate Management from the University of Laval (Canada) and graduated from ESIEE, an engineering school, with a specialization in biotechnologies. He has skills in entrepreneurship and was an advisor for innovative startups in the medical field. He co-founded VitaDX and has led the project since 2013. As the acting CEO, he guides and implements strategic decisions of the company.
Allan holds a MBA in International Corporate Management from the University of Laval (Canada) and graduated from ESIEE, an engineering school, with a specialization in biotechnologies. He has skills in entrepreneurship and was an advisor for innovative startups in the medical field. He co-founded VitaDX and has led the project since 2013. As the acting CEO, he guides and implements strategic decisions of the company.
Thibaut is an engineer from the Institut d'Optique specialized in Signal and Image Processing. At the CNRS, he initiated with the researchers at the origin of the patent exploited by VitaDX, the first technical developments. Passionate about data analysis and artificial intelligence, he is in charge of all the image processing and machine learning algorithm’s development. As CTO, his mission is to enable the transition from a laboratory method to an industrial solution, which can be commercialized.
Thibaut is an engineer from the Institut d'Optique specialized in Signal and Image Processing. At the CNRS, he initiated with the researchers at the origin of the patent exploited by VitaDX, the first technical developments. Passionate about data analysis and artificial intelligence, he is in charge of all the image processing and machine learning algorithm’s development. As CTO, his mission is to enable the transition from a laboratory method to an industrial solution, which can be commercialized.
Marie is a biotechnology engineer who graduated from UTC Compiègne. With more than 25 years of experience in marketing and sales in healthcare, notably in oncology, she joined VitaDX in May 2022 to support it in its commercial deployment.
Marie is a biotechnology engineer who graduated from UTC Compiègne. With more than 25 years of experience in marketing and sales in healthcare, notably in oncology, she joined VitaDX in May 2022 to support it in its commercial deployment.
Raphaël has extensive experience in quality and regulatory management within companies specializing in medical devices through the structuring of a quality management system and CE marking applications for the marketing of medical solutions. Raphaël is in charge of structuring the quality and regulatory processes within VitaDX and he also supervises the entire regulatory strategy to ensure complete consistency with the company's strategy.
Raphaël has extensive experience in quality and regulatory management within companies specializing in medical devices through the structuring of a quality management system and CE marking applications for the marketing of medical solutions. Raphaël is in charge of structuring the quality and regulatory processes within VitaDX and he also supervises the entire regulatory strategy to ensure complete consistency with the company's strategy.
35000 Rennes, France
75015 Paris, France
We are constantly on the lookout for new talent. You can consult our offers or submit a spontaneous application.